Sort
51,593 grants matching “hepatitis”
RNA silencing machinery in extracellular vesicle-mediated immunometabolic regulation
$615,239Takahisa Nakamura · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · DK
Therapeutic miRNA Modulation of Hepatocellular Carcinoma Using Ultrasound Guided Drug Delivery
$615,180Ramasamy Paulmurugan · Stanford University · R01 · FY2019 · CA
Dynamic Strategies for the clinical management of HIV disease
$615,167Miguel Hernan · Harvard University D/B/A Harvard School Of Public Health · R37 · FY2025 · AI
Contextual risk factors for hepatitis C among young persons who inject drugs
$615,121Basmattee Boodram · University Of Illinois At Chicago · R01 · FY2020 · DA
Biomarkers of Alcoholic Hepatitis
$615,104Gavin E Arteel · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · AA
Mechanisms of Advanced NAFLD Disparities in Hispanics: A Multi-level Analysis
$615,034Veronica Wendy Setiawan · University Of Southern California · R01 · FY2023 · MD
Probing the antibody response to HCV to facilitate rational immunogen design
$614,982Dennis R. Burton · Scripps Research Institute, The · R01 · FY2010 · AI
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
$614,941David Y Hui · University Of Cincinnati · R01 · FY2022 · HL
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
$614,941David Y Hui · University Of Cincinnati · R01 · FY2025 · HL
Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis
$614,941David Y Hui · University Of Cincinnati · R01 · FY2023 · HL
Developmental Funds
$614,904Scott M Lippman · University Of California, San Diego · P30 · FY2023 · CA
Innate Immune Response to Hepatocyte Death
$614,851Ian Nicholas Crispe · University Of Washington · R01 · FY2016 · AI
Fecal microbiota transplant for Alcohol-Associated Cirrhosis
$614,842Jasmohan S Bajaj · Virginia Commonwealth University · R01 · FY2025 · AA
Immune correlates of protection against hepacivirus persistence.
$614,828Amit Kapoor · Research Inst Nationwide Children'S Hosp · R01 · FY2023 · AI
Immune correlates of protection against hepacivirus persistence.
$614,828Amit Kapoor · Research Inst Nationwide Children'S Hosp · R01 · FY2022 · AI
Immune correlates of protection against hepacivirus persistence.
$614,828Amit Kapoor · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · AI
Genomics and pharmacodynamics of statin-related rhabdomyolysis
$614,753Bruce M Psaty · University Of Washington · R01 · FY2015 · HL
Hepcidin therapy for iron overload and hematologic disorders
$614,637Stefano Rivella · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · DK
The impact of prenatal exposure to persistent organic pollutants on kinetics of immune response to vaccines and sero-protection in infants
$614,618Steven G. Self · Fred Hutchinson Cancer Research Center · R01 · FY2016 · ES
Genetic Modifiers of CF Liver Disease
$614,590Michael R Knowles · Univ Of North Carolina Chapel Hill · R01 · FY2008 · DK
Developmental Funds
$614,582Scott M Lippman · University Of California, San Diego · P30 · FY2021 · CA
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis B
$614,571Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
INCIDENCE OF HIV INFECTION IN A COHORT OF IV DRUG USERS
$614,532Johns Hopkins University · R01 · FY2003 · DA
Mechanism of ER protein misfolding-induced mitochondrial dysfunction
$614,427Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2017 · DK
Licensing LncRNAs in Atherosclerosis
$614,422Tamer Sallam · University Of California Los Angeles · R01 · FY2024 · HL